Boston Scientific’s Innova Bare Stent for Peripheral Artery Disease FDA Approved
Boston Scientific received FDA approval to introduce its Innova vascular stent in the United States for treating narrowing or occlusions within the superficial femoral or proximal popliteal arteries. The device is made to be both strong and flexible, resisting fracturing while moving through tortuous anatomy and complying with the vessel walls morphology once in position.
The nitinol self-expanding bare stent is the foundation of the Eluvia drug-eluting stent designed specifically for the superficial femoral artery. The Innova device comes in lengths from 20 to 200 mm and diameters from 5 to 8 mm.
Product page: Innova Stent System…
Via: Boston Scientific…
We recommend
- Zilver PTX Drug Eluting Stent Approved for PAD in U.S.Medgadget
- Cook Medical’s Zilver PTX Drug-Eluting Stent Receives Unanimous Recommendation from FDA Advisory CommitteeMedgadget
- Boston Sci's Drug-Eluting Coronary Stents FDA Cleared for Heart Attack VictimsMedgadget
- Boston Scientific REBEL Stent Approved in U.S. (VIDEO)Medgadget
- Does optical coherence tomography identify arterial healing after stenting? An in vivo comparison with histology, in a rabbit carotid model.F Prati et al., Heart, 2007
- Indications for the performance of intracranial endovascular neurointerventional procedures. A scientific statement from the American Heart Association Council on Cardiovascular Radiology and Intervention, Stroke Council, Council on Cardiovascular Surgery and Anesthesia, Interdisciplinary Council on Peripheral Vascular Disease, and Interdisciplinary Council on Quality of Care and Outcomes Research.Philip M Meyers et al., J Neurointerv Surg, 2010
- A novel model of in-stent restenosis: rat aortic stenting.H C Lowe et al., Heart, 2005
- P-024 Stress distribution after intracranial stent by realistic modelM Fujimoto et al., J Neurointerv Surg, 2012
© Medgadget, LLC. 2004-2015. All rights reserved.
No comments:
Post a Comment
Please leave a comment-- or suggestions, particularly of topics and places you'd like to see covered